Redmond Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Sell
1,282
-10
-0.8% -$10.1K 0.32% 99
2025
Q4
$1.39M Hold
1,292
0.35% 92
2025
Q3
$986K Hold
1,292
0.24% 120
2025
Q2
$1.01M Sell
1,292
-50
-4% -$38.9K 0.24% 120
2025
Q1
$1.11M Hold
1,342
0.29% 106
2024
Q4
$1.04M Buy
+1,342
New +$1.11M 0.26% 114

Other funds holding LLY

Redmond Asset Management's LLY Position: Q1 2026 in Review

Redmond Asset Management reduced its Eli Lilly (LLY) stake by 0.77% in Q1 2026, selling an estimated $10.1K and leaving 1,282 shares worth $1.18M. The position accounts for 0.32% of the portfolio, ranked #99.

Redmond Asset Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.39M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Redmond Asset Management held 1,282 shares of Eli Lilly worth $1.18M as of Q1 2026.
  • Redmond Asset Management sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.32% of Redmond Asset Management's portfolio in Q1 2026, its #99 holding.
  • Redmond Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Redmond Asset Management's Eli Lilly position peaked at $1.39M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Redmond Asset Management's 13F filing for Q1 2026, filed 6 May 2026.